{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:29:23Z","timestamp":1779244163288,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015739","name":"Bayer Vital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>About 25% of all ischaemic strokes are related to cardio-embolism, most often due to atrial fibrillation (AF). Little is known about the extent and standardization of routine cardiac diagnostic work-up at certified stroke-units in Germany.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The MonDAFIS study included non-AF patients with acute ischaemic stroke or transient ischaemic attack (TIA) at 38 certified stroke-units in Germany. Here, we analysed routine diagnostic work-up and disregarded study-related Holter-ECG monitoring. We compared duration of stroke-unit stay, number of 24-h Holter-ECGs, and echocardiography performed between university-based comprehensive stroke centres (UCSC, 12 hospitals, 1606 patients), non university-based comprehensive stroke centres (nUCSC, 14 hospitals, 892 patients), and primary stroke centres at non-university hospitals (PCS, 12 hospitals, 933 patients) using multivariable mixed regression analyses. Detection of a first AF episode in-hospital was also compared between hospitals of different stroke-unit levels.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In 3431 study patients (mean age 66.2\u00a0years, 39.5% female, median NIHSS\u2009=\u20092 on admission), median duration of the stroke-unit stay was 72\u00a0h (IQR 42\u201386). Stroke-unit stay was longer (categorised \u2264\u200924\/\u2009&gt;\u200924-\u2009\u2264\u200972\/\u2009&gt;\u200972\u00a0h) for patients with severe stroke (NIHSS score \u2265\u20095\/\u2009&lt;\u20095: OR\u2009=\u20091.6, 95%CI 1.3\u20132.0) and for patients with ischaemic stroke vs. TIA (OR\u2009=\u20091.7, 95%CI 1.4\u20132.1). Overall, 2149\/3396 (63.3%) patients underwent at least one additional 24-h Holter-ECG (median 1 [IQR 0\u20131], range 0\u20137). Holter-ECG rate was 47% in UCSC, 71% in nUCSC, and 84% in PCS. Compared to PCS, AF was less often detected in-hospital in UCSC (OR\u2009=\u20090.65, 95%CI 0.45\u20130.93) and nUCSC (OR\u2009=\u20090.69, 95%CI 0.46\u20131.04). Transoesophageal echocardiography (TEE) only was performed in 513\/3391 (15.1%) study patients, transthoracic echocardiography (TTE) only in 1228\/3391 (36.2%), and TEE combined with TTE in 1020\/3391 (30.1%) patients. Patients younger than 60\u00a0years (vs.\u2009\u2265\u200960\u00a0years) underwent TEE more often than those older than 60\u00a0years (OR\u2009=\u20093.44, 95%CI 2.67\u20134.42). TEE (IQR 34\u201365%) and TTE rate (IQR 40\u201385%) varied substantially among study centres. Echocardiography rate (TTE and\/or TEE) was 74.0% in UCSC, 85.4% in nUCSC, and 90.3% in PSC, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In the MonDAFIS study, the routine use of echocardiography and Holter-ECG monitoring varied in participating stroke centres and at stroke-unit level, if grouped according to stroke-unit certification grade and hospitals\u00b4 university status.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> Clinical Trials, NCT02204267. Registered 30 July 2014, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02204267\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02204267<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42466-023-00246-8","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T01:02:08Z","timestamp":1685581328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Extent of routine diagnostic cardiac work-up at certified German stroke units participating in the prospective MonDAFIS study"],"prefix":"10.1186","volume":"5","clinical-trial-number":[{"clinical-trial-number":"nct02204267","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Manuel C.","family":"Olma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"T\u00fct\u00fcnc\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Grittner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Jawad-Ul-Qamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"R\u00f6ther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6tz","family":"Thomalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Veltkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Laufs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darius G.","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter U.","family":"Heuschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Endres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6389-5054","authenticated-orcid":false,"given":"Karl Georg","family":"Haeusler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"issue":"18","key":"246_CR1","doi-asserted-by":"publisher","first-page":"e1768","DOI":"10.1212\/WNL.0000000000012767","volume":"97","author":"C Carcel","year":"2021","unstructured":"Carcel, C., Harris, K., Peters, S. A. E., Sandset, E. C., Balicki, G., Bushnell, C. D., Howard, V. J., Reeves, M. J., Anderson, C. S., Kelly, P. J., & Woodward, M. (2021). Representation of women in stroke clinical trials: A review of 281 trials involving more than 500,000 participants. Neurology, 97(18), e1768\u2013e1774. https:\/\/doi.org\/10.1212\/WNL.0000000000012767","journal-title":"Neurology"},{"key":"246_CR2","doi-asserted-by":"crossref","unstructured":"Diener, H. C., Grau, A. J., Baldus, S., Ghanem, A., Groeschel, K., Liebetrau, C., Massberg, S., M\u00f6llmann, H., Nef, H., Sander, D., Weimar, C. (2018). Kryptogener Schlaganfall und offenes Foramen ovale, S2e Leitlinie. Deutsche Gesellschaft f\u00fcr Neurologie, Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie.","DOI":"10.1007\/s00115-018-0609-y"},{"issue":"11","key":"246_CR3","doi-asserted-by":"publisher","first-page":"e012714","DOI":"10.1136\/bmjopen-2016-012714","volume":"6","author":"O Geraghty","year":"2016","unstructured":"Geraghty, O., Korompoki, E., Filippidis, F. T., Rudd, A., & Veltkamp, R. (2016). Cardiac diagnostic work-up for atrial fibrillation after transient ischaemic attacks in England and Wales: Results from a cross-sectional survey. British Medical Journal Open, 6(11), e012714. https:\/\/doi.org\/10.1136\/bmjopen-2016-012714","journal-title":"British Medical Journal Open"},{"issue":"10","key":"246_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00392-018-1256-9","volume":"107","author":"KG Haeusler","year":"2018","unstructured":"Haeusler, K. G., Gr\u00f6schel, K., K\u00f6hrmann, M., Anker, S. D., Brachmann, J., B\u00f6hm, M., Diener, H.-C., Doehner, W., Endres, M., Gerloff, C., Huttner, H. B., Kaps, M., Kirchhof, P., Nabavi, D. G., Nolte, C. H., Pfeilschifter, W., Pieske, B., Poli, S., Sch\u00e4bitz, W. R., \u2026 Schnabel, R. (2018). Expert opinion paper on atrial fibrillation detection after ischemic stroke. Clinical Research in Cardiology, 107(10), 871\u2013880. https:\/\/doi.org\/10.1007\/s00392-018-1256-9","journal-title":"Clinical Research in Cardiology"},{"key":"246_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ahj.2015.10.010","volume":"172","author":"KG Haeusler","year":"2016","unstructured":"Haeusler, K. G., Kirchhof, P., Heuschmann, P. U., Laufs, U., Busse, O., Kunze, C., Thomalla, G., Nabavi, D. G., R\u00f6ther, J., Veltkamp, R., & Endres, M. (2016). Impact of standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (MonDAFIS): Rationale and design of a prospective randomized multicenter study. American Heart Journal, 172, 19\u201325. https:\/\/doi.org\/10.1016\/j.ahj.2015.10.010","journal-title":"American Heart Journal"},{"issue":"6","key":"246_CR6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1474-4422(21)00067-3","volume":"20","author":"KG Haeusler","year":"2021","unstructured":"Haeusler, K. G., Kirchhof, P., Kunze, C., T\u00fct\u00fcnc\u00fc, S., Fiessler, C., Malsch, C., Olma, M. C., Jawad-Ul-Qamar, M., Kr\u00e4mer, M., Wachter, R., & Michalski, D. (2021). Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study. The Lancet Neurology., 20(6), 426\u2013436. https:\/\/doi.org\/10.1016\/S1474-4422(21)00067-3","journal-title":"The Lancet Neurology."},{"key":"246_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","author":"G Hindrics","year":"2020","unstructured":"Hindrics, G., Potpara, T., & Dagres, N. (2020). 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"European Heart Journal"},{"issue":"6","key":"246_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1159\/000518934","volume":"50","author":"P Langhorne","year":"2021","unstructured":"Langhorne, P. (2021). The stroke unit story: where have we been and where are we going? Cerebrovascular Diseases, 50(6), 636\u2013643. https:\/\/doi.org\/10.1159\/000518934","journal-title":"Cerebrovascular Diseases"},{"key":"246_CR9","doi-asserted-by":"publisher","first-page":"CD000197","DOI":"10.1002\/14651858.CD000197.pub4","volume":"4","author":"P Langhorne","year":"2020","unstructured":"Langhorne, P., & Ramachandra, S. (2020). Organised inpatient (stroke unit) care for stroke: Network meta-analysis. Cochrane Database of Systematic Reviews, 4, CD000197. https:\/\/doi.org\/10.1002\/14651858.CD000197.pub4","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"246_CR10","doi-asserted-by":"publisher","unstructured":"Nabavi, D. G., Koennecke, H. C., Ossenbrink, M., Grau, A., Busse, O., die Stroke Unit Kommission, den Zertifizierungsausschuss der DSG, den Vorstand der DSG, den Zertifizierungsausschuss der DSG. (2019). Certification criteria for stroke units in Germany: update 2018. Der Nervenarzt, 90, 335\u2013342. doi:https:\/\/doi.org\/10.1007\/s00115-018-0633-y","DOI":"10.1007\/s00115-018-0633-y"},{"issue":"6","key":"246_CR11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s42451-021-00379-7","volume":"4","author":"T Neumann-Haefelin","year":"2021","unstructured":"Neumann-Haefelin, T., Busse, O., Faiss, J., Koennecke, H. C., Ossenbrink, M., Steinmetz, H., & Nabavi, D. (2021). Zertifizierungskriterien f\u00fcr stroke-units in Deutschland: Update 2022. DGNeurologie, 4(6), 438\u2013446. https:\/\/doi.org\/10.1007\/s42451-021-00379-7","journal-title":"DGNeurologie"},{"issue":"4","key":"246_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/2396987318808719","volume":"3","author":"B Norrving","year":"2018","unstructured":"Norrving, B., Barrick, J., Davalos, A., Dichgans, M., Cordonnier, C., Guekht, A., Kutluk, K., Mikulik, R., Wardlaw, J., Richard, E., Nabavi, D., Molina, C., Bath, P. M., Sunnerhagen, K. S., Rudd, A., Drummond, A., Planas, A., & Caso, V. (2018). Action plan for stroke in Europe 2018\u20132030. European Stroke Journal, 3(4), 309\u2013336. https:\/\/doi.org\/10.1177\/2396987318808719","journal-title":"European Stroke Journal"},{"issue":"1","key":"246_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s42466-022-00229-1","volume":"5","author":"T Rizos","year":"2023","unstructured":"Rizos, T., Jenetzky, E., Nabavi, D. G., Haeusler, K. G., Wachter, R., Mrtin Ossenbrink, P. A., & Ringleb, O. B. (2023). Echocardiography in acute stroke patients: A nationwide analysis in departments with certified stroke units in Germany. Neurological Research and Practice, 5(1), 3. https:\/\/doi.org\/10.1186\/s42466-022-00229-1","journal-title":"Neurological Research and Practice"},{"issue":"6","key":"246_CR14","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/strokeaha.115.009374","volume":"46","author":"T Rizos","year":"2015","unstructured":"Rizos, T., Quilitzsch, A., Busse, O., Haeusler, K. G., Endres, M., Heuschmann, P., & Veltkamp, R. (2015). Diagnostic work-up for detection of paroxysmal atrial fibrillation after acute ischemic stroke: Cross-sectional survey on German stroke units. Stroke, 46(6), 1693\u20131695. https:\/\/doi.org\/10.1161\/strokeaha.115.009374","journal-title":"Stroke"},{"issue":"7","key":"246_CR15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s00392-021-01834-x","volume":"110","author":"RB Schnabel","year":"2021","unstructured":"Schnabel, R. B., Camen, S., Knebel, F., Hagendorff, A., Bavendiek, U., B\u00f6hm, M., Doehner, W., Endres, M., Gr\u00f6schel, K., Goette, A., Huttner, H. B., Jensen, C., Kirchhof, P., Korosoglou, G., Laufs, U., Liman, J., Morbach, C., Nabavi, D. G., Neumann-Haefelin, T., \u2026 Haeusler, K. G. (2021). Expert opinion paper on cardiac imaging after ischemic stroke. Clinical Research in Cardiology, 110(7), 938\u2013958. https:\/\/doi.org\/10.1007\/s00392-021-01834-x","journal-title":"Clinical Research in Cardiology"},{"issue":"22","key":"246_CR16","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1161\/CIRCULATIONAHA.119.040267","volume":"140","author":"RB Schnabel","year":"2019","unstructured":"Schnabel, R. B., Haeusler, K. G., Healey, J. S., Freedman, B., Boriani, G., Brachmann, J., Brandes, A., Bustamante, A., Casadei, B., Crijns, H. J. G. M., Doehner, W., Engstr\u00f6m, G., Fauchier, L., Friberg, L., Gladstone, D. J., Glotzer, T. V., Goto, S., Hankey, G. J., Harbison, J. A., \u2026 Yan, B. (2019). Searching for atrial fibrillation poststroke: A white paper of the AF-SCREEN international collaboration. Circulation, 140(22), 1834\u20131850. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.040267","journal-title":"Circulation"},{"issue":"3","key":"246_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/2396987318778971","volume":"3","author":"U Waje-Andreassen","year":"2018","unstructured":"Waje-Andreassen, U., Nabavi, D. G., Engelter, S. T., Dippel, D. W. J., Jenkinson, D., Skoda, O., Zini, A., Orken, D. N., Staikov, I., & Lyrer, P. (2018). European Stroke Organisation certification of stroke units and stroke centres. European Stroke Journal, 3(3), 220\u2013226. https:\/\/doi.org\/10.1177\/2396987318778971","journal-title":"European Stroke Journal"},{"issue":"5","key":"246_CR18","doi-asserted-by":"publisher","first-page":"e0216530","DOI":"10.1371\/journal.pone.0216530","volume":"14","author":"K Wasser","year":"2019","unstructured":"Wasser, K., Weber-Krueger, M., Juerries, F., Liman, J., Hamann, G. F., Kermer, P., Uphaus, T., Protsenko, E., Seegers, J., Mende, M., & Groeschel, K. (2019). The cardiac diagnostic work-up in stroke patients\u2014A subanalysis of the Find-AFRANDOMISED trial. PLoS ONE, 14(5), e0216530. https:\/\/doi.org\/10.1371\/journal.pone.0216530","journal-title":"PLoS ONE"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-023-00246-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-023-00246-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-023-00246-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T01:03:47Z","timestamp":1685581427000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurolrespract.biomedcentral.com\/articles\/10.1186\/s42466-023-00246-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["246"],"URL":"https:\/\/doi.org\/10.1186\/s42466-023-00246-8","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]},"assertion":[{"value":"10 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The MonDAFIS study was approved by the Ethics Committee of participating study sites, first by the Charit\u00e9 Ethics Committee, Berlin, Germany (EA2_033_14). All study patients gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ST, UG, CK, MJUQ, and MO report no conflict of interests outside the submitted work. PK receives research support for basic, translational, and clinical research projects from European Union, British Heart Foundation, Leducq Foundation, Medical Research Council (UK), and German Centre for Cardiovascular Research, from several drug and device companies active in atrial fibrillation, and has received honoraria from several such companies in the past. PK is listed as inventor on two patents held by University of Birmingham (Atrial Fibrillation Therapy WO 2015140571, Markers for Atrial Fibrillation WO 2016012783). GT has received speaker\u00b4s honoraria or consulting fees from Acandis, Bayer Healthcare, Boehringer Ingelheim, Covidien, Bristol-Myers-Squibb, Portola, Stryker and Pfizer, and is a section editor of Neurological Research and Practice.  DGN has received speaker's and consulting fees from Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol-Myers-Squibb, Pfizer, an Daiichi Sankyo. JR has received speaker\u00b4s honoraria and consulting fees from Bayer, Boehringer Ingelheim, Bristol-Myers-Squibb, Pfizer, Daiichi Sankyo, Alexion and Astra Zeneca. UL reports honoraria\/reimbursements for lectures, participation in studies, scientific cooperations (with Saarland University), consulting, travel, support (of colleagues) or support of scientific meetings by Amgen, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, MSD, Sanofi, Servier outside the submitted work. RV reports grants, personal fees and other from Bayer, grants from Boehringer, grants and personal fees from BMS, grants from Daiichi Sankyo, grants from Medtronic, personal fees from Javelin, grants from Biogen, grants and personal fees from Pfizer, personal fees from Abbott, personal fees from Astra Zeneca, other from Novartis, outside the submitted work, and is an editorial board member of Neurological Research and Practice. RV is an investigator of Imperial BRC and partially funded by the European Union's Horizon 2020 research and innovation programme under grant agreement No. 754517 (PRESTIGE-AF). PUH reports grants from Charit\u00e9 - Universit\u00e4tsmedizin Berlin during study conduct (within MonDAFIS for biometry; member scientific board); research grants from German Ministry of Research and Education, German Research Foundation, Bavarian State, European Union, German Cancer Aid, German Parkinson Society, University Hospital W\u00fcrzburg, German Heart Foundation, Federal Joint Committee (G-BA) within the Innovationsfonds, University Hospital Heidelberg (within RASUNOA-prime; supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer, BMS, Boehringer-Ingelheim, Daiichi Sankyo), University G\u00f6ttingen (within FIND-AF randomized; supported by an unrestricted research grant to the University G\u00f6ttingen from Boehringer-Ingelheim), outside the submitted work. ME reports grants from Bayer and fees paid to the Charit\u00e9 from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers-Squibb, Covidien, Daiichi Sankyo, Glaxo Smith Kline, Novartis, Pfizer, and Sanofi, and is an editorial board member of Neurological Research and Practice. KGH reports speaker\u00b4s honoraria, consulting fees, lecture honoraria and\/or study grants from Abbott, Alexion, Amarin, AstraZeneca, Bayer Healthcare, Sanofi, Boehringer Ingelheim, Boston Scientific, Daiichi Sankyo, Pfizer, Bristol-Myers Squibb, Biotronik, Medtronic, Novartis, Portola, Getemed AG, Premier Research, W.L. Gore and Associates, SUN Pharma and Edwards Lifesciences.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}